Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wanaka

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Biopolymers|June 25, 1999
Development of plasma kallikrein selective inhibitorsY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|January 6, 2001
Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationshipY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|November 29, 2001
Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitorsY Tsuda, M Tada, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1993
Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationshipN Teno, K Wanaka, Y Okada, et al.
International Journal of Peptide and Protein Research|January 1, 1986
Synthesis of plasmin substrates and relationship between their structure and plasmin activityY Okada, Y Tsuda, N Teno, et al.
Biological & Pharmaceutical Bulletin|May 31, 2001
Isolation of plasma kallikrein by high efficiency affinity chromatography and its characterizationM Tada, Y Tsuda, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1991
Development of active center-directed inhibitors against plasminN Teno, K Wanaka, Y Okada, et al.
Journal of Biochemistry|February 28, 2001
Binding diversity of a noncovalent-type low-molecular-weight serine protease inhibitor and function of a catalytic water molecule: X-ray crystal structure of PKSI-527--inhibited trypsinK Tomoo, K Satoh, Y Tsuda, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1991
Development of selective inhibitors against plasma kallikreinN Teno, K Wanaka, Y Okada, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Highly selective synthetic inhibitors with regard to plasma-kallikrein activitiesS Okamoto, U Okamoto, K Wanaka, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Biopolymers|June 25, 1999
Development of plasma kallikrein selective inhibitorsY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|January 6, 2001
Development of potent and selective plasmin and plasma kallikrein inhibitors and studies on the structure-activity relationshipY Okada, Y Tsuda, M Tada, et al.
Chemical & Pharmaceutical Bulletin|November 29, 2001
Structure-inhibitory activity relationship of plasmin and plasma kallikrein inhibitorsY Tsuda, M Tada, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|June 1, 1993
Development of active center-directed plasmin and plasma kallikrein inhibitors and studies on the structure-inhibitory activity relationshipN Teno, K Wanaka, Y Okada, et al.
International Journal of Peptide and Protein Research|January 1, 1986
Synthesis of plasmin substrates and relationship between their structure and plasmin activityY Okada, Y Tsuda, N Teno, et al.
Biological & Pharmaceutical Bulletin|May 31, 2001
Isolation of plasma kallikrein by high efficiency affinity chromatography and its characterizationM Tada, Y Tsuda, K Wanaka, et al.
Chemical & Pharmaceutical Bulletin|September 1, 1991
Development of active center-directed inhibitors against plasminN Teno, K Wanaka, Y Okada, et al.
Journal of Biochemistry|February 28, 2001
Binding diversity of a noncovalent-type low-molecular-weight serine protease inhibitor and function of a catalytic water molecule: X-ray crystal structure of PKSI-527--inhibited trypsinK Tomoo, K Satoh, Y Tsuda, et al.
Chemical & Pharmaceutical Bulletin|November 1, 1991
Development of selective inhibitors against plasma kallikreinN Teno, K Wanaka, Y Okada, et al.
Advances in Experimental Medicine and Biology|January 1, 1989
Highly selective synthetic inhibitors with regard to plasma-kallikrein activitiesS Okamoto, U Okamoto, K Wanaka, et al.
Pageof 3